| |
| |
|
| Insider
Information: |
Shema Suzanne M |
| Relationship: |
EVP,GC and Corp. Secre... |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
100 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
100 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zymogenetics Inc |
ZGEN |
Senior VP, General Cou... |
2008-01-17 |
100 |
2005-05-09 |
0 |
Premium* |
|
|
Onyx Pharmaceuticals Inc |
ONXX |
EVP,GC and Corp. Secre... |
2013-10-01 |
0 |
2009-08-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONXX |
Onyx Pharmaceuticals Inc |
SVP, General Counsel |
• – – |
2009-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
11,000 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
SVP, General Counsel |
• – – |
2010-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
15,500 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
SVP, General Counsel |
• – – |
2010-08-31 |
4 |
D |
$24.09 |
$32,425 |
D/D |
(1,346) |
14,154 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
SVP, General Counsel |
• – – |
2011-03-31 |
4 |
D |
$35.18 |
$19,349 |
D/D |
(550) |
31,604 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
SVP, General Counsel |
• – – |
2011-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
32,154 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
SVP, General Counsel |
• – – |
2011-09-01 |
4 |
S |
$34.14 |
$46,191 |
D/D |
(1,353) |
30,251 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
SVP, General Counsel |
• – – |
2012-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
24,650 |
54,901 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
SVP, General Counsel |
• – – |
2012-04-02 |
4 |
D |
$36.58 |
$46,161 |
D/D |
(1,262) |
53,639 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, General Counsel & Sec |
• – – |
2012-06-07 |
4 |
OE |
$30.28 |
$1,264,900 |
D/D |
40,000 |
93,639 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, General Counsel & Sec |
• – – |
2012-06-07 |
4 |
AS |
$44.44 |
$1,781,091 |
D/D |
(40,000) |
53,639 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, General Counsel & Sec |
• – – |
2012-07-09 |
4 |
AS |
$67.49 |
$1,655,646 |
D/D |
(24,466) |
53,639 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, General Counsel & Sec |
• – – |
2012-07-09 |
4 |
OE |
$30.28 |
$770,808 |
D/D |
24,466 |
78,105 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, General Counsel & Sec |
• – – |
2012-07-25 |
4 |
AS |
$73.97 |
$219,770 |
D/D |
(2,971) |
50,668 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, General Counsel & Sec |
• – – |
2012-08-06 |
4 |
AS |
$71.93 |
$471,146 |
D/D |
(6,550) |
44,118 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, General Counsel & Sec |
• – – |
2012-08-07 |
4 |
AS |
$71.79 |
$1,218,308 |
D/D |
(16,933) |
44,118 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, General Counsel & Sec |
• – – |
2012-08-07 |
4 |
OE |
$30.28 |
$593,559 |
D/D |
16,933 |
61,051 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, GC and Corp, Secretary |
• – – |
2012-09-04 |
4 |
AS |
$72.78 |
$125,254 |
D/D |
(1,721) |
42,397 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, GC and Corp. Secretary |
• – – |
2012-09-07 |
4 |
AS |
$77.88 |
$155,838 |
D/D |
(2,001) |
42,397 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, GC and Corp. Secretary |
• – – |
2012-09-07 |
4 |
OE |
$30.28 |
$62,998 |
D/D |
2,001 |
44,398 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, GC and Corp. Secretary |
• – – |
2012-10-08 |
4 |
AS |
$91.01 |
$182,020 |
D/D |
(2,000) |
36,147 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, GC and Corp. Secretary |
• – – |
2012-10-08 |
4 |
OE |
$30.28 |
$62,966 |
D/D |
2,000 |
38,147 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, GC and Corp. Secretary |
• – – |
2012-11-07 |
4 |
OE |
$30.28 |
$62,996 |
D/D |
2,001 |
38,148 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, GC and Corp. Secretary |
• – – |
2012-11-07 |
4 |
AS |
$75.14 |
$150,355 |
D/D |
(2,001) |
36,147 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, GC and Corp. Secretary |
• – – |
2012-12-10 |
4 |
AS |
$77.68 |
$1,118,437 |
D/D |
(14,398) |
33,833 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP, GC and Corp. Secretary |
• – – |
2012-12-10 |
4 |
OE |
$30.28 |
$434,905 |
D/D |
12,084 |
48,231 |
0 |
- |
|
68 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
